Table 2.
Clinicopathologic variables and the expression status of miR-302b
| Variables | N |
miR-302b |
P | |
|---|---|---|---|---|
| Low | High | |||
| Age |
|
|
|
0.168 |
| <65 |
34 |
21 |
13 |
|
| ≥65 |
16 |
13 |
3 |
|
| Gender |
|
|
|
0.863 |
| Male |
29 |
20 |
9 |
|
| Female |
21 |
14 |
7 |
|
| Smoking |
|
|
|
0.301 |
| Yes |
37 |
27 |
11 |
|
| No |
13 |
7 |
6 |
|
| Drink |
|
|
|
0.137 |
| Yes |
30 |
18 |
12 |
|
| No |
20 |
16 |
4 |
|
| Differentiation |
|
|
|
0.010 |
| Well + Moderate |
39 |
23 |
16 |
|
| Poor |
11 |
11 |
0 |
|
| TNM stage |
|
|
|
0.230 |
| I–II |
19 |
11 |
8 |
|
| III–IV |
31 |
23 |
8 |
|
| Lymph node status |
|
|
|
0.001 |
| Metastasis |
30 |
26 |
4 |
|
| No metastasis | 20 | 8 | 12 | |